Cargando…
Monotherapy efficacy of blood–brain barrier permeable small molecule reactivators of protein phosphatase 2A in glioblastoma
Glioblastoma is a fatal disease in which most targeted therapies have clinically failed. However, pharmacological reactivation of tumour suppressors has not been thoroughly studied as yet as a glioblastoma therapeutic strategy. Tumour suppressor protein phosphatase 2A is inhibited by non-genetic mec...
Autores principales: | Merisaari, Joni, Denisova, Oxana V, Doroszko, Milena, Le Joncour, Vadim, Johansson, Patrik, Leenders, William P J, Kastrinsky, David B, Zaware, Nilesh, Narla, Goutham, Laakkonen, Pirjo, Nelander, Sven, Ohlmeyer, Michael, Westermarck, Jukka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425423/ https://www.ncbi.nlm.nih.gov/pubmed/32954276 http://dx.doi.org/10.1093/braincomms/fcaa002 |
Ejemplares similares
-
Circumventing Drug Treatment? Intrinsic Lethal Effects of Polyethyleneimine (PEI)-Functionalized Nanoparticles on Glioblastoma Cells Cultured in Stem Cell Conditions
por: Prabhakar, Neeraj, et al.
Publicado: (2021) -
Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells
por: Denisova, Oxana V., et al.
Publicado: (2022) -
PP2A‐based triple‐strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells
por: Denisova, Oxana V., et al.
Publicado: (2023) -
(2S, 4R)-4-[(18)F]Fluoroglutamine for In vivo PET Imaging of Glioma Xenografts in Mice: an Evaluation of Multiple Pharmacokinetic Models
por: Miner, Maxwell WG, et al.
Publicado: (2020) -
Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression
por: Eriksson, Johanna, et al.
Publicado: (2016)